Tutelyan V.A., Sharafetdinov Kh.Kh., Kochetkova A.A.Monograph:
ISBN: 978-5-9909278-9-6
Format: 60х84/16
Amount: 500
Published: 23.01.2017
Publisher: BIBLIO-GLOBUS Publishing House


Keywords: carbohydrate profile modification, foods for special dietary uses, insulin resistance, modern principles of dietary therapy, nutritional factor, postprandial blood glucose, type 2 diabetes mellitus


Share:

Abstract:

The present work is dedicated to the relevant issues in Nutrition Science and Dietology, the latest data concerning the role of genetic and environmental factors in the development of type 2 diabetes mellitus, the significance of dietary factor in the correction of postprandial blood glucose, the influence of the nutrition factor on the main pathogenetic mechanisms underlying this disease, modern principles of dietary therapy at type 2 diabetes mellitus. In the monograph, theoretical and practical aspects of the development of specialist foods with modified carbohydrate profile for the patients suffering from type 2 diabetes mellitus have been discussed. The possibilities and prospects of using special confectionery products in the complex therapy of type 2 diabetes mellitus have been identified. The monograph may be of interest for dieticians, endocrinologists, specialists in food tech-nologies, as well as for students of medical schools and professional advancement courses in Dietology and Nutrition Science.

---

References:
1. Aksenova L.M., Savenkova T.V. Osnovnye napravleniya raz-vitiya proizvodstva muchnyh konditerskikh izdeliy // Sbornik statey «Pischevye ingredienty v proizvodstve khlebobulochnyh i muchnyh konditerskikh izdeliy». – M.: DeLi plyus, 2013. – S. 14–20.
2. Algoritmy spetsializirovannoy meditsinskoy pomoschi bolnym sakharnym diabetom / Pod red. I.I. Dedova, M.V. Shestakovoy. – MZ RF, RDA, FGBU «Endokrinologicheskiy na-uchnyy tsentr». – 6 izd. – 2013. – 120 s.
3. Alekseeva R.I. Vliyanie dietoterapii s vklyucheniem poli-nenasyschennyh zhirnyh kislot semeystva -3 na kliniko-metabolicheskie pokazateli u bolnyh sakharnym diabetom 2 tipa: Avtoref. diss. ... kand.med.nauk. – M., 2002.
4. Ametov A.S. Sakharnyy diabet 2 tipa. Problemy i resheniya. – 2-e izd., pererab. i dop. – M., GEOTAR-Media, 2013. – 1032 s.
5. Ametov A.S., Melnik A.V. Upravlenie sakharnym diabetom: rol postprandialnoy giperglikemii i vozmozhnosti ee korrek-tsii // RMZh. – 2007. – T.15. – № 27 (308). – S. 2053–2058.
6. Balobolkin M.I. Diabetologiya. – M.: Meditsina, 2000. – 672 s.
7. Balabolkin M.I., Klebanova E.M., Kreminskaya V.M. Lechenie sakharnogo diabeta i ego oslozhneniy: Uchebno-metodicheskoe posobie. – M., OAO «Izdatelstvo «Meditsina», 2005. – 512 s.
8. Balabolkin M.I. Klebanova E.M., Kreminskaya V.M. Znachenie vitaminov i mikronutrientov v podderzhanii kompensatsii ug-levodnogo obmena u bolnyh sakharnym diabetom // Klinicheskaya en-dokrinologiya. – 2007.– № 1. – S. 3–12.
9. Balabolkin M.I., Mikhaylova E.V., Knyazeva A.P., Panko-va S.S. Vliyanie bolshikh doz tokoferola na protsessy perekisnogo okisleniya lipidov i sekretsiyu insulina u bolnyh insulinnezavi-simym sakharnym diabetom // Problemy endokrinologii. – 1994. – T.40, № 3. – S. 10–12.
10. Batashova N.V. Konditerskaya pasta kak bazovaya osnova dlya ras-shireniya assortimenta produktov funktsionalnogo naznacheniya // Kon-diterskoe i khlebopekarnoe proizvodstvo, 2009. – № 5. – S. 26–28.
11. Bessenen D.G., Kushner R. Izbytochnyy ves i ozhirenie. Profilaktika, diagnostika i lechenie. – M.: ZAO «Izdatelstvo BINOM», 2004. – 240 s.
12. Butrova S.A., Dzgoeva F.Kh. Vistseralnoe ozhirenie – klyu-chevoe zveno metabolicheskogo sindroma // Ozhirenie i metabolizm. – 2004. – № 1. – S. 10–16.
13. Vorobyeva V.M., Vorobyeva I.S., Kochetkova A.A., Sharafet-dinov Kh.Kh., Zorina E.E. Modifikatsiya uglevodnogo sostava kondi-terskikh izdeliy dlya bolnyh sakharnym diabetom 2 tipa // Voprosy pitaniya. – 2014. – T.83, № 6. – S. 66–73.
14. Galstyan G.R., Shestakova M.V. Sovremennye vozmozhnosti upravleniya sakharnym diabetom 2 tipa // Consilium Medicum. – 2012. – T.14, № 12. – S. 15–20.
15. Globalnyy plan boryby s diabetom 2011 2021. – Mezhduna-rodnaya federatsiya diabeta. Bryussel, Belgiya, 27 s.
16. GOST 14031 68 «Vafli. Tekhnicheskie usloviya».
17. GOST R 55577 2013 «Produkty pischevye funktsionalnye. Informatsiya ob otlichitelnyh priznakakh i effektivnosti».
18. Dedov I.I. Sakharnyy diabet v Rossii: problemy i resheniya / I.I. Dedov, M.V. Shestakova, Yu.I. Suntsov. – M., 2008. – S. 3–6.
19. Dedov I.I. Sakharnyy diabet: razvitie tekhnologiy v diag-nostike, lechenii i profilaktike (plenarnaya lektsiya) // Sakharnyy diabet. – 2010. – № 3. – S. 6–13.
20. Dedov I.I. Sakharnyy diabet – opasneyshiy vyzov mirovomu soobschestvu // Vestnik Rossiyskoy akademii meditsinskikh nauk. – 2012. – № 1. – S. 7–13.
21. Dedov I.I., Balabolkin M.I., Klebanova E.M. i dr. Sakhar-nyy diabet: patogenez, klassifikatsiya, diagnostika i lechenie. Po-sobie dlya vrachey. – M., 2003. – 171 s.
22. Dedov I.I., Gorelysheva V.A., Smirnova O.M. i dr. Vliyanie antioksidantov na sostoyanie perekisnogo okisleniya lipidov i funktsiyu β-kletok u bolnyh s vpervye vyyavlennym insulinzavi-simym sakharnym diabetom // Problemy endokrinologii. – 1995. – T.41, № 5. – S. 16–20.
23. Dedov I.I., Smirnova O.M., Kononenko I.V. Znachenie re-zultatov polnogenomnyh issledovaniy dlya pervichnoy profilakti-ki sakharnogo diabeta 2 tipa i ego oslozhneniy. Personalizirovannyy podkhod // Sakharnyy diabet. – 2014. – № 2. – S. 10–19.
24. Dedov I.I., Shestakova M.V. Diabeticheskaya nefropatiya. – M.: Universum Pablishing, 2000. – 239 s.
25. Doklad o sostoyanii zdravookhraneniya v mire. Umenyshenie riska, sodeystvie zdorovomu obrazu zhizni. Zheneva, Vsemirnaya or-ganizatsiya zdravookhraneniya, 2002. (http://www.who.int/whr/2002/en/).
26. Dragilev A.I., Sezanaev Ya.M. Proizvodstvo muchnyh kondi-terskikh izdeliy. – M.: DeLi Print, 2000. – 446 s.
27. Edinye sanitarno-epidemiologicheskie i gigienicheskie trebovaniya k tovaram, podlezhaschim sanitarno-epidemiologiches-komu nadzoru (kontrolyu) (utverzhdeny Resheniem Komissii Tamozhennogo soyuza ot 28 maya 2010 goda № 299).
28. Ermolaev V.A., Shushpannikov A.B. Issledovanie pokazatelya aktivnosti vody sukhikh molochnyh produktov // Tekhnika i tekhnologiya pischevyh proizvodstv. – 2010. – № 2 (17). – S. 84–88.
29. Zaytseva L.V., Nechaev A.P., Bessonov V.V. Trans-izomery zhirnyh kislot: istoriya voprosa, aktualnosty problemy, puti re-sheniya. – M.: DeLi plyus, 2012. – 56 s.
30. Zdorovye-2020: osnovy Evropeyskoy politiki v podderzhku deystviy vsego gosudarstva i obschestva v interesakh zdorovyya i bla-gopoluchiya // Malta, Evropeyskiy regionalnyy komitet VOZ. 2012 g. (EUR/RC62/9)
31. Ipatova L.G., Kochetkova A.A. Primenenie pischevyh volokon v razlichnyh gruppakh produktov // Biznes pischevyh ingredientov. – 2008. – № 6. – S. 19–21.
32. Ipatova L.G., Kochetkova A.A., Nechaev A.P. i dr. Pischevye volokna v produktakh pitaniya // Pischevaya promyshlennost. – 2007. – № 5. – S. 8–10.
33. Ipatova L.G., Kochetkova A.A., Nechaev A.P., Tutelyan V.A. Zhirovye produkty dlya zdorovogo pitaniya. Sovremennyy vzglyad. – M.: DeLi plyus, 2009. – 395 s.
34. Ipatova L.G., Kochetkova A.A., Shubina O.G. i dr. Fiziolo-gicheskie i tekhnologicheskie aspekty primeneniya pischevyh volokon // Pischevye ingredienty, syrye i dobavki. – 2004. – № 1. – S. 14–17.
35. Kasatkina E.P., Odud E.A. Ispolzovanie glikemicheskikh indeksov v dietoterapii sakharnogo diabeta (lektsiya) // Problemy endokrinologii. – 1993. – T.39, № 6. – S. 35–37.
36. Klebanova E.M. Vliyanie gipokaloriynoy diety na insuli-novuyu rezistentnost, funktsionalnuyu aktivnosty -kletok i li-pidnyy obmen u bolnyh sakharnym diabetom tipa 2 // Voprosy pi-taniya. – 2006. – T.75, № 3. – S. 32–35.
37. Klebanova E.M. Vliyanie gipokaloriynoy diety na pokaza-teli uglevodnogo obmena i soderzhanie leptina i rastvorimogo re-tseptora k leptinu v syvorotke krovi bolnyh sakharnym diabetom 2-go tipa // Voprosy pitaniya. – 2006. – T.75, № 4. – S. 29–31.
38. Klinicheskie rekomendatsii «Algoritmy spetsializirovan-noy meditsinskoy pomoschi bolnym sakharnym diabetom». 7 izd. / pod red. I.I. Dedova, M.V. Shestakovoy // Sakharnyy diabet. – 2015. – T.18 (1S) – 112 s.
39. Kodentsova V.M. Vitaminy. – M.: OOO «Izdatelstvo «Me-ditsinskoe informatsmonnoe agentstvo», 2015. – 408 s.
40. Kodentsova V.M., Vrzhesinskaya O.A., Sokolnikov A.A. Vi-taminizatsiya pischevyh produktov massovogo potrebleniya: istoriya i perspektivy // Voprosy pitaniya. – 2012. – T.81, № 5.– S. 66–78.
41. Koluell Dzh.A. Sakharnyy diabet. Novoe v lechenii i profi-laktike. – Per. s angl. – M.: BINOM, Laboratoriya znaniy, 2007 – 288 s.
42. Korpachev V.V. Sakhara i sakharozameniteli. – Kiev: Kniga plyus, 2004. – 320 s.
43. Korotkova V.D. Rol pischevyh volokon i lekarstvennyh rasteniy v lechenii sakharnogo diabeta II tipa: diss.…kand.med.nauk. – M., 1991.
44. Kosovan A.P., Shlelenko L.A., Tyurina O.E., Gapparov M.M. G., Sharafetdinov Kh.Kh., Plotnikova O.A., Borisova A.E. Patent № 2434438 «Smesy diabeticheskaya dlya khlebobulochnyh izdeliy s ispolzovaniem grechnevoy muki».
45. Kosovan A.P., Shlelenko L.A., Tyurina O.E., Polandova R.D., Gapparov M.M. G., Sharafetdinov Kh.Kh., Plotnikova O.A. Patent № 2435403 «Smesy diabeticheskaya dlya khlebobulochnyh izdeliy».
46. Koteshkova O.M., Sretenskaya I.S., Antsiferov M.B. Podsla-stiteli v pitanii bolnyh sakharnym diabetom // Farmateka. – 2006. – № 17 (132). – S. 32–36.
47. Krasina I.B. Teoreticheskoe i eksperimentalnoe obosnova-nie sozdaniya diabeticheskikh muchnyh konditerskikh izdeliy s pri-meneniem rastitelnyh biologicheski aktivnyh dobavok: Avtoref. dis…. d-ra tekhn.nauk. – Krasnodar, 2008.
48. Kratkiy analiticheskiy obzor: Kak mogut evropeyskie sis-temy zdravookhraneniya pomochy v investirovanii v strategii okhrany i ukrepleniya zdorovyya naseleniya i v ikh realizatsii? // VOZ. – 2008. – 32 s. (ISSN 1998 4081).
49. Krylova E.N., Savenkova T.V., Mavrina E.N. Ispolzovanie podslastiteley pri proizvodstve molochnyh mass / Sbornik nauchnyh trudov GNU NIIKP Rosselkhozakademii «Nauchnye osnovy razvitiya tekhnologiy konditerskikh izdeliy». – M.: Intellekt-Tsentr. 2013. – S. 230–233.
50. Liflyandskiy V.G., Smolyanskiy B.L. Vse o diete GL. Glike-micheskiy indeks i s chem ego edyat. – SPb.: BKhV-Peterburg, 2006. – 160 s.
51. Mari R., Grene D., Meyes P., Roduell V. Biokhimiya cheloveka. V 2-kh t. T.1: Per. s angl. – M.: Mir, 2004. – 381 s.
52. Martinchik A.N., Maev I.V., Petukhov A.B. Pitanie cheloveka (osnovy nutritsiologii). Pod red.professora A.N. Martinchika. – M.: GOU VUNMTs MZ RF, 2002. – 576 s.
53. Maslova O.V., Suntsov Yu.I. Epidemiologiya sakharnogo dia-beta i mikrososudistyh oslozhneniy // Diabetes mellitus. – 2011. – № 3. – C. 6–12.
54. Materialy Mezhdunarodnoy konferentsii «Torty i pirozh-nye-2010». Khronika i informatsiya. // Konditerskoe proizvodstvo. 2011. – № 1. – S. 32–37.
55. Medvedev Zh.A. Pitanie i dolgoletie. M.: Vremya, 2011. – 528 s.
56. Mescheryakova V.A. Dieticheskaya korrektsiya faktorov riska ishemicheskoy bolezni serdtsa: Diss. … dokt.med.nauk. – M., 1989.
57. Mescheryakova V.A., Plotnikova O.A., Sharafetdinov Kh.Kh., Yatsyshina T.A. Ispolzovanie kombinirovannyh produktov s vklyu-cheniem soevogo belka v dietoterapii bolnyh sakharnym diabetom 2 tipa // Voprosy pitaniya. – 2002. – T.71, № 5. – S. 19–24.
58. Mychka V.B., Chazova I.E. Serdechno-sosudistye oslozhneniya sakharnogo diabeta tipa 2 // Consilium medicum. – 2003. – T.5, № 9. – S. 504–509.
59. Nedosugova L.V., Nikishova M.S., Volkova A.K. i dr. Pri-menenie flavonoidov dikvertina i tanaka v kompleksnoy terapii sakharnogo diabeta tipa 2 // Materialy IX Mezhdunarodnogo syezda «FITOFARM 2005». – SPb., 2005. – S. 613–618.
60. Orlova G.G. Praktikum po zdorovyyu i zdorovomu obrazu zhizni «Ot Salerno do nashikh dney». – Tvery: Alba Plyus, 2004. – 48 s.
61. Parenteralnoe i enteralnoe pitanie: natsionalnoe ruko-vodstvo / pod red. M.Sh. Khubutiya, T.S Popovoy, A.I. Saltanova. – M.: GEOTAR-Media, 2014. – 800 s.
62. Perova N.V. Omega-3 polinenasyschennye zhirnye kisloty v kardiologii // Kardiovaskulyarnaya terapiya i profilaktika. – 2005. – № 4. – S. 101–107.
63. Petunina N.A. Rol rosiglitazona v lechenii sakharanogo diabeta tipa 2 // Kachestvo zhizni. Meditsina. Bolezni endokrinnoy sistemy. – 2006. – № 3 (14). – S. 85–89.
64. Pitanie i zdorovye v Evrope: Novaya osnova dlya deystviy. VOZ. 2003. 38 c. (ISBN 9289043644).
65. Piters-Kharmel E., Matur R. Sakharnyy diabet: diagnostika i lechenie. Per. s angl. – M.: Praktika, 2008. – 496 s.
66. Plan deystviy v oblasti pischevyh produktov i pitaniya na 2015 2020 gg. Kopengagen, Daniya. Evropeyskiy regionalnyy komi-tet. 2014. 24 s. (EUR/RC64/14).
67. Pogozheva A.V. Osnovy ratsionalnoy dietoterapii pri serdechno-sosudistyh zabolevaniyakh // Klinicheskaya dietologiya. – 2004. – T.1, № 2. – S. 17–29.
68. Polyanskiy K.K., Rudakov O.B., Podporinova G.K. Natural-nye i iskusstvennye podslastiteli. Svoystva i ekspertiza kachestva. – M.: Izd. DeLi print. – 2009. – 252 s.
69. Postanovlenie Pravitelstva Rossiyskoy Federatsii ot 25.10.2010 № 1873-r «Osnovy gosudarstvennoy politiki Rossiy-skoy Federatsii v oblasti zdorovogo pitaniya na period do 2020 goda».
70. Rekomenduemye urovni potrebleniya pischevyh i biologiche-ski aktivnyh veschestv. – M.: GSEN RF, 2004. – 42 s.
71. Retseptury «Na konditerskie izdeliya dlya diabetikov». – M.: Legkaya i pischevaya promyshlennost, 1984. – 86 s.
72. Rossiyskaya konditerskaya otrasl na sovremennom etape // Konditerskoe proizvodstvo. – 2010. – № 1. – S. 6–7.
73. Rudnitskaya T.A., Kolpakov M.A. Gipergomotsisteinemiya u bolnyh sakharnym diabetom 2 tipa // Vestnik Novosibirskogo go-sudarstvennogo universiteta. Seriya: Biologiya, klinicheskaya medi-tsina. – 2008. – T.6, № 3. – S. 35–41.
74. Savenkova T.V., Soldatova E.A. Sovremennye podkhody k razrabotke obogaschennyh vafelnyh izdeliy // Materialy nauch.-prakt.konf. – Uglich, 2003. – S. 401–404.
75. Savenkova T.V., Taleysnik M.A., Shatnyuk L.N., Spirichev V.B., Vorobyeva I.S. Obogaschenie konditerskikh izdeliy vitaminami i mineralnymi veschestvami. – M., Filial GMP «Pervaya Obra-zovatelnaya tipografiya», 2003. – 48 s.
76. Sanitarno-epidemiologicheskie trebovaniya k organizatsii pitaniya obuchayuschikhsya v obscheobrazovatelnyh uchrezhdeniyakh, uchrezh-deniyakh nachalnogo i srednego professionalnogo obrazovaniya. Sa-nitarno-epidemiologicheskie pravila i normativy SanPiN 2.4.5.2409 08 (utverzhdeny Postanovleniem Glavnogo gosudarstven-nogo sanitarnogo vracha RF ot 23 iyulya 2008 g. № 45).
77. Sanitarno-epidemiologicheskie trebovaniya k ustroystvu, so-derzhaniyu i organizatsii rezhima raboty doshkolnyh obrazovatelnyh organizatsiy. Sanitarno-epidemiologicheskie pravila i normativy SanPiN 2.4.1.3049 13 (utverzhdeny Postanovleniem Glavnogo gosudarstvennogo sanitarnogo vracha RF ot 15 maya 2013 g. № 26).
78. Sarafanova L.A. Pischevye dobavki: entsiklopediya. – SPb: GIORD. – 2003. – 688 s.
79. Skripchenko N.D. Vliyanie lechebno-profilakticheskoy diety, obogaschennoy selenom, na kliniko-metabolicheskie pokazateli u bolnyh sakharnym diabetom 2 tipa: Avtoref. diss. ... kand.med.nauk. – M., 2003.
80. Skripchenko N.D., Gmoshinskiy I.V., Mescheryakova V.A. i dr. Obespechennosty selenom i pokazateli perekisnogo okisleniya lipi-dov u bolnyh sakharnym diabetom 2 tipa v protsesse dietoterapii i primeneniya selensoderzhaschey BAD // Mikroelementy v meditsine. – M., 2002. - T.3. – № 1. – S. 15–19.
81. Skripchenko N.D., Sharafetdinov X.X., Plotnikova O.A., Mescheryakova V.A. Vliyanie gipokaloriynoy diety na kliniko-metabolicheskie pokazateli u bolnyh sakharnym diabetom 2 tipa" // Voprosy pitaniya. – 2002. – № 4. – S. 13–17.
82. Smirnova O.M. Klinicheskie, immunogeneticheskie, gormo-nalno-metabolicheskie aspekty vpervye vyyavlennogo insulinzavi-simogo sakharnogo diabeta (klinika, diagnostika, lechenie, profi-laktika): Avtoref. diss. ... dokt.med.nauk. – M., 1995.
83. Smolyanskiy B.L., Liflyandskiy V.G. Dietologiya. Noveyshiy spravochnik dlya vrachey. – SPb.: Sova; M.: Eksmo, 2003. – 816 s.
84. Soldatova E.A., Savenkova T.V. Prakticheskie osnovy polu-cheniya izdeliy «zdorovogo» pitaniya na primere muchnyh konditer-skikh izdeliy // Materialy IV mezhd. konf. «Konditerskie izdeliya XXI veka». – M., 2003. – S. 173–176.
85. Spirichev V.B. Nauchnye i prakticheskie aspekty patogene-ticheski obosnovannogo primeneniya vitaminov v profilakticheskikh i lechebnyh tselyakh. Defitsit vitaminov – faktor, oslozhnyayuschiy techenie zabolevaniy i snizhayuschiy effektivnosty lechebno-profilakticheskikh meropriyatiy // Voprosy pitaniya. – 2011. – T.80, № 1. – S. 4–12.
86. Spravochnik po gidrokolloidam // Filips G.O., Vil-yams P.A. (red.). Per. s angl. Pod red. A.A. Kochetkovoy i L.A. Sarafanovoy. – SPb.: GIORD, 2006. – 536 s.
87. Spravochnik po dietologii / Pod red. M.A. Samsonova, A.A. Pokrovskogo. – M.: Meditsina, 1992.
88. Tekhnicheskiy reglament Tamozhennogo soyuza «O bezopasnosti pischevoy produktsii» (TR TS 021/2011).
89. Tekhnicheskiy reglament Tamozhennogo soyuza «O bezopasnosti otdelnyh vidov spetsializirovannoy pischevoy produktsii, v tom chisle dieticheskogo lechebnogo i dieticheskogo profilakticheskogo pitaniya» (TR TS 027/2012).
90. Tekhnicheskiy reglament Tamozhennogo soyuza «Trebovaniya bezopasnosti pischevyh dobavok, aromatizatorov i tekhnologicheskikh vspomogatelnyh sredstv» (TR TS 029/2012).
91. Tekhnicheskiy reglament Tamozhennogo soyuza «Pischevaya pro-duktsiya v chasti eyo markirovki» (TR TS 022/2011).
92. TU 9137 091-00334675-04 «Vafli dieticheskie bez sakhara na izomalte. Tekhnicheskie usloviya».
93. TU 9125 085-00334675-03 «Shokolad dlya dieticheskogo le-chebnogo i dieticheskogo profilakticheskogo pitaniya bez sakhara na izomalte. Tekhnicheskie usloviya» (s izmeneniem № 1, 2).
94. Tutelyan V.A. Khimicheskiy sostav i kaloriynosty rossiyskikh produktov pitaniya: Spravochnik. – M.: DeLi plyus, 2012. – 284 s.
95. Tutelyan V.A., Baygarin E.K., Pogozheva A.V. Pischevye vo-lokna: gigienicheskaya kharakteristika i otsenka effektivnosti. – M.: «SvR-ARGUS», 2012. – 244 s.
96. Tutelyan V.A., Pogozheva A.V., Vysotskiy V.G. i dr. Analiz sovremennyh kontseptsiy o roli produktov pererabotki soevyh bobov v dietoterapii bolnyh s serdechno-sosudistymi zabolevaniyami serdtsa // Vopr.pitaniya. – 2000. – № 5. – S. 43–51.
97. Tutelyan V.A., Pogozheva A.V., Vysotskiy V.G., Baygarin E.K., Zilova I.S., Zhminchenko V.M., Pashorina V.A., Derbenyova S.A. Rol pischevyh volokon v pitanii cheloveka. – M.: «Novoe tysyacheletie», 2008. – 325 s.
98. Tutelyan V.A., Smirnova E.A. Rol pischevyh mikroingre-dientov v sozdanii sovremennyh produktov pitaniya // Sbornik sta-tey «Pischevye ingredienty v sozdanii sovremennyh produktov pi-taniya». – M., DeLi, 2014. – S. 10–24.
99. Tutelyan V.A., Spirichev V.B., Shatnyuk L.N. Obogaschenie khlebobulochnyh i muchnyh konditerskikh izdeliy vitaminami i mi-neralnymi veschestvami. – M., 1999. – 47 s.
100. Tutelyan V.A., Sharafetdinov Kh.Kh., Lapik I.A., Vorobye-va I.S., B.P. Sukhanov B.P. Prioritety v razrabotke spetsializiro-vannyh pischevyh produktov optimizirovannogo sostava dlya bolnyh sakharnym diabetom tipa 2 // Voprosy pitaniya. – 2014. – T.83, № 6. – S. 41–51.
101. Ugolev A.M., Radbil O.S. Gormony pischevaritelnoy sis-temy. – M.: Nauka, 1995. – 283 s.
102. Ulumbekova G.E. Nauchnoe obosnovanie strategii razvitiya zdravookhraneniya RF do 2020 goda: avtoref. dis… kand.med.nauk. – M., 2011.
103. Federalnyy Zakon Rossiyskoy Federatsii ot 02.01.2000 g. № 29-FZ «O kachestve i bezopasnosti pischevyh produktov» (v redak-tsii federalnyh zakonov RF: ot 30.12.2001 g. №196-FZ, ot 10.01.2003 g. №15-FZ ot 30.06.2003 g. №86-FZ, ot 22.08.2004 g. №122-FZ).
104. Khimicheskiy sostav Rossiyskikh pischevyh produktov. Pod red. Skurikhina I.M., Tutelyana V.A. – M.: DeLi Print, 2002. – 235 s.
105. Khimiya pischevyh produktov / Sh. Damodaran, K.L. Parkin, O.R.Fennema. – Perev. s angl. – SPb.: ID «Professiya», 2012. – 1040 s.
106. Sharafetdinov Kh.Kh. Dieticheskaya korrektsiya metabolicheskikh narusheniy pri sakharnom diabete 2 tipa: Avtoref. diss. ... d-ra med. nauk. – M., 2000. – 39 s.
107. Sharafetdinov Kh.Kh., Mescheryakova V.A., Plotnikova O.A. i dr. Vliyanie BAD, soderzhaschey tsink, na kliniko-metabolicheskie pokazateli u bolnyh sakharnym diabetom 2 tipa // Voprosy pitaniya. – 2004. – T.73, № 4. – S. 17–20.
108. Sharafetdinov Kh.Kh., Mescheryakova V.A., Plotnikova O.A. i dr. Vliyanie BAD, soderzhaschey khrom, na kliniko-metabolicheskie pokazateli u bolnyh sakharnym diabetom 2 tipa // Voprosy pitaniya. – 2004. – T.73, № 5. – S. 17–20.
109. Sharafetdinov Kh.Kh., Mescheryakova V.A., Plotnikova O.A. Dinamika poslepischevoy glikemii u bolnyh insulinnezavisimym sakharnym diabetom pod vliyaniem ekstrudirovannyh i mikronizi-rovannyh produktov iz zernovyh i krupyanyh kultur // Voprosy pitaniya. – 1998. – № 3. – S. 30–33.
110. Sharafetdinov Kh.Kh., Mescheryakova V.A., Plotnikova O.A. Izmenenie poslepischevoy glikemii pod vliyaniem nekotoryh ugle-vodsoderzhaschikh produktov u bolnyh sakharnym diabetom II tipa // Voprosy pitaniya. – 1997. – № 1. – S. 27–30.
111. Sharafetdinov Kh.Kh., Mescheryakova V.A., Plotnikova O.A. Sravnitelnaya otsenka poslepischevoy glikemii u bolnyh sakharnym diabetom 2 tipa pri potreblenii mono- i disakharidov i sakharoza-meniteley // Voprosy pitaniya. – 2002. – T.71, № 2. – S. 22–26.
112. Sharafetdinov Kh.Kh., Mescheryakova V.A., Plotnikova O.A., Chernyak O.I. Vliyanie razlichnyh istochnikov belka na uroveny po-slepischevoy glikemii pod u bolnyh sakharnym diabetom II tipa // Probl.endokrinol. – 1995. – № 2. – S. 14–17.
113. Sharafetdinov Kh.Kh., Plotnikova O.A. Innovatsionnye podkhody v lechenii sakharnogo diabeta tipa 2: rol spetsializiro-vannogo produkta dlya enteralnogo pitaniya «Glyutserna SR» // Far-mateka. 2010. № 3 (197) Endokrinologiya. C.73–78.
114. Sharafetdinov Kh.Kh., Plotnikova O.A., Zykina V.V., Alek-seeva R.I. Sovremennaya strategiya lechebnogo pitaniya pri sakharnom diabete tipa 2 // Voprosy pitaniya. – 2008. – T.77, № 2. – S. 23–31.
115. Sharafetdinov Kh.Kh., Plotnikova O.A., Kulakova S.N. i dr. Vliyanie diety, obogaschennoy mononenasyschennymi zhirnymi ki-slotami, na kliniko-metabolicheskie pokazateli u bolnyh sakharnym diabetom 2 tipa // Voprosy pitaniya. – 2003. – № 4. – S. 20–23.
116. Sharafetdinov Kh.Kh., Plotnikova O.A., Mescheryakova V.A. Lechebnoe pitanie pri sakharnom diabete tipa 2 // Kachestvo zhizni. Meditsina. Bolezni endokrinnoy sistemy. – 2006. – № 4. – S. 104–109.
117. Shatnyuk L.N. Nauchnye osnovy tekhnologiy dieticheskikh produktov s ispolzovaniem vitaminov i mineralnyh veschestv: Avtoref. diss….d-ra tekhn.nauk. – M., 2000.
118. Shatnyuk L.N., Savenkova T.V. Muchnye konditerskie izdeliya, obogaschennye vitaminami i mineralnymi veschestvami // Sbornik statey «Pischevye ingredienty v proizvodstve khlebobulochnyh i muchnyh konditerskikh izdeliy». – M.: DeLi plyus, 2013. – S. 190–220.
119. Shterman S.V. Novaya alternativa starym uglevodam // Konditerskoe proizvodstvo. – 2009. – № 5. – S. 10–11.
120. Shubina O.G. Polidekstroza – mnogofunktsionalnyy ugle-vod dlya sozdaniya nizkokaloriynyh i obogaschennyh produktov // Pischevaya promyshlennost. – 2005. – № 5. – S. 28–31.
121. Adamo KB, Ferraro ZM, Brett KE. Can we modify the intrau-terine environment to halt the intergenerational cycle of obesity? // Int.J.Environ.Res.Public Health. – 2012. – Vol.9. – P.1263–1307.
122. Akanji A.O., Charles-Davies M.A., Ezenwaka C., Abbiyesuku F.A., Osotimehin B.O. Dietary salt and the glycaemic re-sponse to meals of different fibre content // Eur.J.Clin.Nutr. – 1989. – Vol.43, № 10. – P.699–703.
123. Althuis M.D., Jordan N.E., Ludington E.A., Wittes J.T. Glucose and insulin responses to dietary chromium supplements: a meta-analysis // Am.J.Clin.Nutr. – 2002. – Vol.76. – P.148–155.
124. American Diabetes Association: Evidence-based nutrition prin-ciples and recommendations for the treatment and prevention of diabetes and related complications (position statement) // Diabetes Care. – 2003. – Vol.26. – P.S51–S61.
125. American Diabetes Association: Position Statement: Dyslipidemia Management in Adults With Diabetes // Diabetes care. – 2004. – Vol.27 (Suppl.1). – R. S68–S71.
126. American Diabetes Association. Nutrition Recommendations and Interventions for Diabetes A position statement of the American Diabetes As-sociation // Diabetes care. – 2008. – Vol.31 (Suppl.1). – R. S61–S78.
127. American Diabetes Association: Standards of medical care in diabetes-2007 // Diabetes Care. – 2007. – Vol.30 (suppl.1). – P.S4–S41.
128. American Diabetes Association. Standards of Medical Care in Diabetes – 2014 // Diabetes Care. – 2014. – Vol.37 (Suppl.1). – P.S14–S80.
129. Anderson R.A. Chromium, glucose intolerance and diabetes // J.Am.Coll.Nutr. – 1998. – Vol.17. – P.548–555.
130. Anderson R.A., Roussel A.-M., Zouari N. et al. Potential antiox-idant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus // J.Am.Coll.Nutr. – 2001. – Vol.20. – P.212–218.
131. Anderson J.W. Diabetes mellitus: medical nutrition therapy // Modern nutrition in health and disease. 8th ed. / M.E.Shils; associate edi-tors, M.Shike….. [et al.]. 10th ed. 2006. – P.1043–1066.
132. Anurandra C.V., Balakrihman S.D. Taurine attenuates hyperten-sion and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance // Can.J.Physiol.Prarmacol. – 1999. – Vol.77. – P.749–754.
133. Arnold L., Mann J.I., Ball M.J. Metabolic effects of alterations in meal frequency in type 2 diabetes // Diabetes Care. – 1997. – Vol.20, № 11. – R.1651–1654.
134. Aston L.M. Glycemic index and metabolic disease risk // Proc.Nutr.Soc. – 2006. – Vol.65. – R.125–134.
135. Babu P.V., Liu D. Green tea catechins and cardiovascular health: an update // Curr.Med.Chem. – 2008. – Vol.15. – P.1840–1850.
136. Bahijri S.M., Mufti A.M. Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status // Biol.Trace.Elem.Res. – 2002. – Vol.85 – P.97–109.
137. Balk E.M., Tatsioni A., Lichtenstein A.H. et al. Effect of chro-mium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials // Diabetes Care. – 2007. – Vol.30. – P.2154–2163.
138. Bantle A.E., Thomas W., Bantle J.P. Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus // Metabolism. – 2008. – Vol.57. – P.241–245.
139. Barclay A.W., Petocz P., McMillan-Price J. et al. Glycemic in-dex, glycemic load, and chronic disease risk – a meta-analysis of observa-tional studies // Am.J.Clin.Nutr. – 2008. – Vol.87. – P.627–637.
140. Basciano H., Federico L., Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia // Nutr.Metlab (Lond). – 2005. – Vol.2. – P.5.
141. Behall K.M., Scholfield D.J., Canary J. Effect of starch structure on glucose and insulin responses in adults // Am.J.Clin.Nutr. – 1988. – Vol.47, № 3. – P.428–432.
142. Behall K.M., Scholfield D.J., Hallfrisch J. Barley β-glucan re-duces plasma glucose and insulin responses compared with resistant starch in men // Nutr.Res. – 2006. – Vol.26. – R.644–650.
143. Benini L., Gastellani G., Brighenti F. et al. Gastric emptying of a solid meal is accelerated by the removal of dietary fibre naturally present in food // Gut. – 1995. – Vol.36, № 6. – P.825–830.
144. Bloomgarden Z.T. Diet and Diabetes // Diabetes Care. – 2004. – Vol.27. – P.2755–2760.
145. Boden G., Laakso M. Lipids and glucose in type 2 diabetes. What is the cause and effect? // Diabetes Care. – 2004. – Vol.27. – P.2253–2259.
146. Bogardus C., Ravussin E., Robbins D.C. et. al. Effects of physi-cal training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin dependent diabetes mellitus // Diabe-tes. – 1984. – Vol.33, № 4. – P.311–318.
147. Brand J.C., Nicholson P.L., Thorburn A.W., Truswell A.S. Food processing and the glycemic index // Am.J.Clin.Nutr. – 1985. –- Vol. 42, № 6. – P.1192–1196.
148. Brand-Miller J.C. Glycemic index in relation to coronary disease // Asia Pac.J.Clin.Nutr. – 2004. – Vol.13 (Suppl.). – R.S3.
149. Bray G.A., Lovejoy J.C., Smith S.R. et al. The influence of dif-ferent fats and fatty acids on obesity, insulin resistance and inflammation // J.Nutr. – 2002. – Vol.132. – P.2488–2491.
150. Bray G.A., Nielsen S.J., Popkin B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity // Am.J.Clin.Nutr. – 2004. – Vol.79. – P.537–543.
151. Brosnan J. Interorgan amino acid transport and its regulation // J.Nutr. – 2003. – Vol.133 (6 Suppl 1). – P.2068S–2072S.
152. Brynes A.E., Adamson J., Dornhorst A., Frost G.S. The benefi-cial effect of a diet with low glycaemic index on 24 h glucose profiles in healthy young people as assessed by continuous glucose monitoring // Br.J.Nutr. – 2005. – Vol.93. – P.179–182.
153. Brynes A.E., Lee J.L., Brighton R.E. et al. A low glycemic diet significantly improves the 24-h blood glucose profile in people with type 2 diabetes, as assessed using the continuous glucose MiniMed monitor // Diabetes Care. – 2003. – Vol.26. – P.548–549.
154. Buse J.B., Ginsberg H.N., Bakris G.L. et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus // Diabetes Care. – 2007. – Vol.30. – P.162–172.
155. Calbet J.A., MacLean D.A. Plasma glucagon and insulin re-sponses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans // J.Nutr. – 2002. – Vol.132. – P.2174–2182.
156. Cameron– Smith D., Habito R., Barnett M., Collier G.R. Dietary guar gum improves insulin sensitivity in streptozotocin-induced diabetic rats // J.Nutr. – 1997. – Vol.127. – P.359–364.
157. Capstick F., Brooks B.A., Burns C.M. et al. Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient // Diabetes Res.Clin.Pract. – 1997. – Vol.36, № 2. – P.105–111.
158. Carbohydrates in human nutrition. Report of joint FAO/WHO export consultation. FAO Food and Nutrition paper no 66. – 1998.
159. Catena C., Giacchetti G., Novello M. et al. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension // Am.J.Hypertens. – 2003. – Vol.16. – P.973–978.
160. Cefalu W.T., Frank B., Hu F.B. Role of chromium in human health and in diabetes // Diabetes Care. – 2004. – Vol.27. – P.2741–2751.
161. Chacra A.R. Efeito fisiológico das incretinas // Johns Hopkins Advanced Studies in Medicine. – 2006. – Vol.6 (7V). – P.613–617.
162. Chiasson J.-L., Josse R.G., Hunt J.A. et al. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. Multicentrer Controlled Clinical Trial // Ann.Inter.Med. – 1994. – Vol.121, № 12. – P.928–935.
163. Chiasson J.-L., Rabasa-Lhoret R. Prevention of type 2 diabetes. Insulin resistance and beta-cell function // Diabetes. – 2004 – Vol.53. – R.S34–S38.
164. Collier G., O’Dea K. The effect of coingestion of fat on the glu-cose, insulin and gastric inhibitory polypeptide responses to carbohydrate and protein // Am.J.Clin.Nutr. – 1983. – Vol.37, № 6. – P.941–944.
165. Colling P., Williams C., Macdonald I. Effects of cooking on se-rum glucose and insulin response to starch // Br.Med.J. – 1981. – Vol.282 (6269). – P.1032.
166. Collins R.W., Anderson J.W. Medication cost savings associated with weight loss for obese non-insulin-dependent diabetic men and women // Prev.Med. – 1995. – Vol.24, № 4. – P.369–374.
167. Comission Regulation (EU) No 536/2013 of 11 June 2013 amending Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods other than those referring to the reduction of disease risk and to children’s development and health // Official Journal of the European Union. – 2013. L.160. – P.4–8.
168. Commission Regulation (EU) № 432/2012 of 16 May 2012 es-tablishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health // Official Journal of the European Union. – 2012. L 136. – R.1–40.
169. Crapo P.A., Insel J., Sperling M., Kolterman O.G. Comparison of serum glucose, insulin and glucagon responses to different types of complex carbohydrates in non-insulin-dependent diabetic patients // Am.J.Clin.Nutr. – 1981. – Vol.34, № 2. – P.184–190.
170. Crapo P.A., Kolterman O.G., Olefsky J.M. Effects of oral fruc-tose in normal, diabetic, and impaired glucose tolerance subjects // Diabe-tes Care. – 1980. – Vol.3, № 5. – P.575–582.
171. Crapo P.A., Kolterman O.G., Waldeck N. Et al. Postprandial hormonal responses to different types of complex carbohydrates in indi-vidual with impaired glucose tolerance // Am.J.Clin.Nutr. – 1980. – Vol.33, № 8. – P.1723–1728.
172. Crapo P.A., Reaven G., Olefsky J. Plasma glucose and insulin responses to orally administered simple and complex carbohydrates // Di-abetes. – 1976. – Vol.25, № 9. – P.741–747.
173. Crapo P.A., Reaven G., Olefsky J. Postprandial plasma-glucose and -insulin 6esponses to different complex carbohydrates // Diabetes. – 1977. – Vol.26, № 12. – P.1178–1183.
174. Crowther C.A., Hiller J.E., Moss J.R. et al. Australian Carbohy-drate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Ef-fect of treatment of gestational diabetes mellitus on pregnancy outcomes // N.Engl.J.Med. – 2005. – Vol.352. – P.2477–2486.
175. D'Alessandro M.E., Lombardo Y.B., Chicco A. Effect of dietary fish oil on insulin sensitivity and metabolic fate of glucose in the skeletal muscle of normal rats // Ann.Nutr.Metab. – 2002. – Vol.46. – P. 114–120.
176. D'Andrea G. Classifying amino acids as gluco(glyco)genic, ketogenic, or both // Biochem Educ. – 2000. – Vol.28, N 1. – P.27–28.
177. Daly M. Sugars, insulin sensitivity, and the postprandial state // Am.J.Clin.Nutr. – 2003. – Vol.78. – P. 865S–872S.
178. Davies M.J., Metcalfe J., Day J.L. et al. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitus // Dia-betic Med. – 1994. – Vol.11, № 1. – R.71–78.
179. Davies M.J., Rayman G., Day J.L. et al. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in sub-jects with impaired glucose tolerance // Diabetic Med. – 1993. – Vol.10, № 4. – R.313–320.
180. Deane AM, Nguyen NQ, Stevens JE, et al. Endogenous gluca-gon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia // J.Clin.Endocrinol.Metab. – 2010. – Vol.95. – P.215–221.
181. DeFronzo R.A. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: a balanced overview // Diabetology. – 1992. – Vol.35. – P.389–397.
182. Delarue J., LeFoll C., Corporeau C., Lucas D. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity // Reprod.Nutr.Dev. – 2004. – Vol.44. – P.289–299.
183. Denke M.A. Dietary prescriptions to control dyslipidemias // Circulation. – 2002. – Vol.105. – P.132.
184. Dickinson S., Brand-Miller J. Glycemic index, posprandial glycemia and cardiovascular disease // Curr.Opin.Lipidol. – 2005. – Vol.16. – R.69–75.
185. Dirlewanger M., Schneiter P., Jéquier E., Tappy L. Effects of fructose on hepatic glucose metabolism in humans // Am.J.Physiol. Endocrinol. Metab. – 2000. – Vol.279. – P. E907–E911.
186. Djousse L., Biggs M.L., Lermaitre R.N. et al. Plasma omega-3 fatty acids and incident diabetes in older adults // Am.J.Clin>Nutr. – 2011. – Vol.94, N 2. – P.527–533.
187. Driscoll H.K1, Adkins C.D., Chertow T.E., Cordle M.B., Mat-thews K.A., Chertow B.S. Vitamin A stimulation of insulin secretion: ef-fects on transglutaminase mRNA and activity using rat islets and insulin-secreting cells // Pancreas. – 1997. – Vol.15, N 1. – P.69–77.
188. Duska F., Fndel M., Kubena A., Macdonald I.A. Effect of acute starvation on insulin resistance in obese patients with and without type 2 diabetes mellitus // Clin.Nutr. – 2005. – Vol.24. – P.1056–1064.
189. Elliott S.S., Keim N.L., Stern J.S. et al. Fructose, weight gain, and the insulin resistance syndrome // Am.J.Clin.Nutr. – 2002. – Vol.76. – P.911–922.
190. Englyst H.N., Kingman S.M. Carbohydrates. // Human nutrition and dietetics. 9-th ed. / Ed. J.S.Garrow, W.P.T. James. – Edinburg: Churchill Livihgstone, 1993. – P.38–55.
191. Erkkila A, de Mello VD, Risérus U, Laaksonen DE. Dietary fatty acids and cardiovascular disease: an epidemiological approach // Prog.Lipid Res. – 2008. – Vol.47. – P.172–187.
192. Esteves de Oliveira F.C., Pinheiro Volp A.C., Alfenas R.C. Im-pact of different protein sources in the glycemic and insulinemic responses // Nutr.Hosp. – 2011. – Vol.26, N 4. – P.669–676.
193. Evans J.L., Goldfine I.D. Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabe-tes // Diabetes Technol.Ther. – 2000. – Vol.2, № 3. – P.401–413.
194. Evert A.B., Boucher J.L., Cypress M. et al. Nutrition Recom-mendation for the Management of Adults with Diabetes // Diabetes Care. – 2014. – Vol.37 (Suppl.1). – P.S120–S143.
195. Fats and oils in human nutrition. Report of a joint expert consul-tation. FAO food and nutrition paper 57. – Rome, 1994.
196. Flint A., Kapitza C., Hindsberger C., Zdravcovic M. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type diabetes patients // Adv.Ther. – 2011. – Vol.28, N.3. – P.213–226.
197. Foster-Powell K., Holt S.H.A, Brand-Miller J.C. International table of glycemic index and glycemic load values: 2002 // Am.J.Clin.Nutr. – 2002. –Vol.76. – P.5–56.
198. Franz M.J., Bantle J.P., Beebe C.A. et al. Evidence-based nutri-tion principles and recommendations for the treatment and prevention of diabetes and related complications // Diabetes Care. – 2002. – Vol.25. – P.148–198.
199. Franz M.J., Horton E.S., Bantle J.P. et al. Nutrition principles for the management of diabetes and related complications // Diabetes Care. – 1994. – Vol.17, № 5. – P.490–518.
200. Franz M.J., Powers M.A., Leontos C., et al. The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults // J.Am.Diet.Assoc. – 2010. – Vol.110. – R.1852–1889.
201. Franz MJ, Splett PL, Monk A, et al. Cost-effectiveness of medi-cal nutrition therapy provided by dietitians for persons with non-insulin dependent diabetes mellitus // J.Am.Diet.Assoc. – 1995. – Vol.95. – R.1018.
202. Fung T.T., Manson J.E., Solomon C.G. et al. The association between magnesium intake and fasting insulin concentration in healthy middle-aged women // J.Am.Coll.Nutr. – 2003. – Vol.22. – P.533–538.
203. Gannon M.C., Nuttall F.Q. Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabe-tes // Diabetes. – 2004. – Vol.53. – R.2375–2382.
204. Gannon M.C., Nuttall J.A., Damberg G. et al. Effect of protein ingestion on the glucose appearance rate in people with type 2 diabetes // J.Clin.Endocrinol.Metab. – 2001. – Vol.86. – R.1040–1047.
205. Gannon M.C., Nuttall F.Q., Krezowski P.A. et al. The serum in-sulin and plasma glucose responses to milk and fruit products in type 2 (non-insulin-dependent) diabetic patients // Diabetologia. – 1986. – Vol.29, № 11. – P.784–791.
206. Gannon M.C., Nuttall F.Q., Neil B.J., Westphal S.A. The insulin and glucose response to meals of glucose plus various proteins in type II diabetic subjects // Metabolism. – 1988. – Vol.37, № 11. – P.1081–1088.
207. Gannon M.C., Nutall F.Q., Saeed A. et al. An increase in dietary protein improves the blood glucose response in persons with type 2 diabe-tes // Am.J.Clin.Nutr. – 2003. – Vol.78. – P.734–741.
208. Gannon M.C., Nuttall F.Q, Westphal S.A. et al. Effects of dose ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects // Diabetes Care. – 1989. – Vol.12, № 8. – P.544–552.
209. Gans R.O., Heine R.J., Donker A.J., van der Veen E.A. Influence of salt on glycaemic response to carbohydrate loading // Br Med J (Clin Res Ed). – 1987. – Vol.294 (6582). – R.1252–1253.
210. Garg A. Regional adiposity and insulin resistance // J.Clin.Endocrinol.Metab. – 2004. – Vol.89. – P.4206 4210.
211. Gastaldelli A., Cusi K., Pettiti M., Hardies J. et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects // Gastroenterology. – 2007. – Vol.133, № 2. – P.496–506.
212. Gastaldelli A., Miyazaki Y., Pettiti M. et al. Metabolic effects of visceral fat accumulation in type 2 diabetes // J.Clin.Endocrinol.Metab. – 2002. – Vol.87. – P.5098–5103.
213. Gentilcore D., Chaikomin R., Jones K.L., et al. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes // J.Clin.Endocrinol.Metab. – 2006. – Vol.91. – R.2062–2067.
214. Giancaterini A., De Gaetano A., Mingrone G. et al. Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients // Metabolism. – 2000. – Vol.49. – P.704–708.
215. Goddard M.S., Young G., Marcus R. The effect of amylose con-tent on insulin and glucose response to ingested rice // Am.J.Clin.Nutr. – 1984. – Vol.39, № 3. – P.388–392.
216. Godfrey KM, Barker DJP, Robinson S, Osmond C. Maternal birthweight and diet in pregnancy in relation to the infant’s thinness at birth // Br.J.Obstet.Gynaecol. – 1997. – Vol.104. – P.663–667.
217. Goff L.M., Cowland D.E., Hooper L., Frost G.S. Low glycaemic index diets and blood lipids: a systematic review and meta– analysis of randomised controlled trials // Nutr.Metab.Cardiovasc.Dis. – 2013. – Vol.23, № 1. – R.1–10.
218. Gottsater A., Szelag B., Kangro M. et al. Plasma adiponectin and serum advanced glycated end-products increase and plasma lipid concentrations decrease with increasing duration of type 2 diabetes // Eur.J.Endocrinol. – 2004. – Vol.151. – P.361–366.
219. Gower B.A., Weinsier R.L., Jordan J.M. et al. Effects of weight loss on changes in insulin sensitivity and lipid concentrations in premen-opausal African American and white women // Am.J.Clin.Nutr. – 2002. – Vol.76. – P.923–927.
220. Gulliford M.C., Bicknell E.J., Scarpello J.H. Differential effect of protein and fat ingestion on blood glucose responses to high- and low-glycemic-index carbohydrates in noninsulin-dependent diabetic subjects // Am.J.Clin.Nutr. – 1989. – Vol.50, № 4. – P.773–777.
221. Gumbiner B., Polonsky K.S., Beltz W.F. et al. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus // J.Clin. Endocrinol.Metab. – 1990. – Vol.70, № 6. – P.1594–1602.
222. Gunnerud U.J., Heinzle C., Holst J.J., et al. Effects of pre-meal drinks with protein and amino acids on glycemic and metabolic responses at a subsequent composite meal. PLoS One. 2012 7/9: e44731.
223. Hamano Y. Effects of dietary lipoic acid on plasma lipid, in vivo insulin sensitivity, metabolic response to corticosterone and in vitro li-polysis in broiler chickens // Br.J.Nutr. – 2006. – Vol.95, № 6. – P.1094–1101.
224. Hanley AJ et al. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study // Diabetes. – 2002. – Vol.51. – P.1263–1270.
225. Hansen H.P., Tauber-Lassen E., Jensen B.R., Parving H.H. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy // Kidney Int. – 2002. – Vol.62. – P.220–228.
226. Hansen L., Deacon C.F., Orskov C., Holst J.J. Glucagon-like peptide-1-(7 36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of porcine intestine // Endocrinology. – 1999. – Vol.140, № 11. – P.5356–5363.
227. Harris K.A., Kris-Etherton P.M. Effects of whole grains on cor-onary heart disease risk // Curr.Atherocler.Rep. – 2010. – Vol.12, № 6. – P.368–376.
228. Hasanain B., Mooradian A.D. Antioxidant vitamins and their influence in diabetes mellitus // Curr.Diab.Rep. – 2002. – Vol.2. – P.448–456.
229. Hätönen K.A., Virtamo J., Eriksson J.G., et al. Protein and fat modify the glycaemic and insulinaemic responses to a mashed potato-based meal // Br.J.Nutr. – 2011. – Vol.106, № 2. – P.248–253.
230. Heaton K.W., Marcus S.N., Emmett P.M., Bolton C.H. Particle size of wheat, maize and oat test meals: effects on plasma glucose and in-sulin responses and on the rate of starch digestion in vitro // Amer.J.Clin.Nutr. – 1988. – Vol.47, № 4. – P.675–682.
231. Henry R.R. Protein content of the diabetic diet // Diabetes Care. – 1994. – Vol.17, № 12. – P.1502–1513.
232. Henry R.R., Gumbriner B. Benefits and limitations of very-low-calorie diet therapy in obese NIDDM // Diabetes Care. – 1991. – Vol.14, № 9. – P.802–823.
233. Henry R.R., Wallace P., Olefsky J.M. Effects of weight loss on mechanism of hyperglycemia in obese non-insulin-dependent diabetes mellitus // Diabetes. – 1986. – Vol.35, № 9. – P.990–998.
234. Higdon J.V., Frei B. Tea catechins and polyphenols: health ef-fects, metabolism, and antioxidant functions // Crit.Rev.Food Sci.Nutr. – 2003. – Vol.43. – P.89–143.
235. Higgins J.A. Resistant starch: metabolic effects and potential health benefits // J. AOAC Int. – 2004. – Vol.87. – P.761–768.
236. Hillier T.A., Pedula K.L., Schmidt M.M. et al. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007;30:2287 2292
237. Himsworth H.P. Dietetic factor determining glucose tolerance and sensitivity to insulin of healthy men // Clin.Sci. – 1935. – Vol.2. – P.67–94.
238. Hodgson J.M. Effects of tea and tea flavonoids on endothelial function and blood pressure: a brief review // Clin.Exp.Pharmacol.Physiol. – 2006. – Vol.33. – P.838–841.
239. Holst J.J., Vilsboll T., Deacon C.F. The incretin system and its role in type 2 diabetes mellitus // Mol.Cell Endocrinol. – 2009. – Vol.297. – P.127–136.
240. Hosker J.P., Kumar S., Gorden C. et al. Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity but has no effect on insulin sensitivity // Diabetic Med. – 1993. – Vol.10, № 6 – P.509–513.
241. Hotta K., Funahashi T., Arita Y. et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients // Arterioscler.Thromb.Vasc.Biol. – 2000. – Vol.20. – P.1595–1599.
242. Hu F.B., Manson J.E., Willett W.C. Types of dietary fat and risk of coronary heart disease: A critical review // J.Am.Coll.Nutr. – 2001. – Vol.20. – P.5–19.
243. Hu F.B, Willett W.C. Optimal diets for prevention of coronary heart disease // JAMA. – 2002. – Vol.288. – P.2569–2578.
244. Hughes T.A., Gwynne J.T., Switzer B.R. et al. Effects of caloric restriction and weight loss on glycemic control, insulin release and re-sistance, and atherosclerotic risk in obese patients with type II diabetes mellitus // Am.J.Med. – 1984. – Vol.77, № 1. – P.7–17.
245. Hui L., Nelson E.A.S., Choi K. et al. Twelve-hour glycemic profiles with meals of high, medium, or low glycemic load // Diabetes Care 28:2981–2983, 2005.
246. International Diabetes Federation // IDF Diabetes. Atlas. – 7th edition. – 2015.
247. Izydorczyk M.S., Macri L.J., MacGregor A.W. Structure and physicochemical properties of barley non-starch polysaccharides – I. Wa-ter-extractable β-glucans and arabinoxilans. // Carbohydrate Polymers. – 1998. – Vol.35. – P.249–258.
248. Jenkins D.J.A., Kendall C.W.C., Augustin L.S.A. et al. Glycemic index: overview of implications in health and disease // Am.J.Clin.Nutr. – 2002. – Vol.76. – R.266S–273S.
249. Jenkins D.J.A., Ocana A., Jenkins A.L. et al. Metabolic ad-vantages of spreading the nutrient load: effects of increased meal fre-quency in non-insulin-dependent diabetes // Am.J.Clin.Nutr. – 1992. – Vol.55, № 2. – P.461–467.
250. Jenkins D.J.A., Wesson V., Wolever T.M.S. et al. Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response // Br.Med.J. – 1988. – Vol.297 (6654). – P.958–960.
251. Jenkins D.J.A., Wolever T.M.S., Jenkins A.L. Diet factors af-fecting nutrient absorption and metabolism // Modern nutrition in health and disease. 8th ed. / Ed. M.E.Shils, J.A.Olson, M.Shike. – 1994. – P.583–602.
252. Jenkins D.J.A., Wolever T.M.S., Jenkins A.L. Starchy foods and glycemic index // Diabetes Care. – 1988. – Vol.11, № 2. – P.846–854.
253. Jenkins D.J.A., Wolever T.M.S., Jenkins A.L. et al. The glycemic response of foods tested in diabetic patients: a new basis of foods carbohydrate exchange favouring the use of legumes // Diabetologia. – 1983. – Vol.24, № 4. – P.257–264.
254. Jenkins D.J.A., Wolever T.M.S., Taylor R.H. et al. Glycemic index of foods: a physiological basis for carbohydrate exchange // Am.J.Clin.Nutr. – 1981. – Vol.34, № 3. – P.362–366.
255. Jenkins D.J.A., Wolever T.M.S., Vuksan V. Nibbiling versus gorging: metabolic advantages of increased meal frequency // N.Engl.J.Med. – 1989. – Vol.321, № 14. – P.929–934.
256. Johnston C.S., Buller A.J. Vinegar and peanut products as com-plementary foods to reduce postprandial glycemia // J. Am.Diet.Assoc. – 2005. – Vol.105, № 12. – P.1939–1942.
257. Kapitza C., Flint A., Hindsberger C., Zdravcovic M. The effect of the once-daily human GLP-1 analogue liraglutide on the pharmacokinetics of paracetamol // Diabetes. – 2008. – Vol.57 (Suppl.1). – P.A593.
258. Kavanagh K., Jones K.L., Sawyer J. et al. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys // Obesi-ty (Silver Spring) – 2007. – Vol.15. – P.1675–1684.
259. Keenan M.J., Zhou J., Hegsted M. et al.Role of Resistant Starch in Improving Gut Health, Adiposity, and Insulin Resistance // Adv. Nutr. – 2015. – Vol.6. – P.198–205.
260. Keim N.L., Levin R.J., Havel P.J. Carbohydrates // Modern nu-trition in health and disease. 8th ed. / M.E.Shils; associate editors, M.Shike….. [et al.]. 10th ed. 2006. – P.62–82.
261. Kelly G.S. Insulin resistance: lifestyle and nutritional interven-tions // Altern.Med.Rev. – 2000. – Vol.5. – R.109–132.
262. Kendall C.W., Augustin L.S., Emam A. et al. The glycemic in-dex: methodology and use // Nestle Nutr.Workshop Ser.Clin.Perform. Programme. – 2006. – Vol.11. – P.43–56.
263. Kieffer T.J., Habener J.L.. The glucagon-like peptides // Endocr.Rev. – 1999. – Vol.20, № 6. – P.876–913.
264. Kleefstra N., Houweling S.T., Jansman F.G. et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial // Diabetes Care. – 2006. – Vol.29. – P.521–525.
265. Klein S., Fontana L., Young V.L. et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease // N.Engl.J.Med. – 2004. – Vol.350. – R.2549–2557.
266. Klein S., Sheard N.F., Pi-Sunyer X. et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition // Am.J.Clin.Nutr. – 2004. – Vol.80. – P.257–263.
267. Korc M. Diabetes mellitus in the era of proteomics // Mol.Cell.Proteomics – 2003. – Vol.2. – R.399–404.
268. Kris-Etherton P.M., Lichtenstein A.H., Howard B.V. et al. Anti-oxidant vitamin supplements and cardiovascular disease // Circulation. – 2004. – Vol.110. – P.637–641.
269. Kromhout D., Menotti A., Bloemberg B. et al.: Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study // Prev.Med. – 1995. – Vol.24. – P.308–315.
270. Laakso M., Uustupa M., Takala J. et al. Effects of hypocalorie diet and insulin therapy on metabolic control and mechanisms of hyper-glycemia in obese non– insulin-independent diabetic subjects // Metabo-lism. – 1988. – Vol.37, № 11. – R.1092–1100.
271. Lau C., Færch K., Glümer C. et al. Dietary Glycemic Index, Glycemic Load, Fiber, Simple Sugars, and Insulin Resistance. The Inter99 study // Diabetes Care – 2005. – Vol.28. – R.1397–1403.
272. Lazear J., Kapustin J. Vitamin D Deficiency and Type 2 Diabe-tes: A Retrospective Review // The Journal for Nurse Practitioners. – 2014. – Vol.10, N.3. – R. 175–182.
273. Lee W.J., Song K.H., Koh E.H. et al. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle // Biochem.Biophys.Res.Commun. – 2005. – Vol.332. – P.885–891.
274. Lee Y.M., Haastert B., Scherbaum W., Hauner H. A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus: a randomized controlled trial under free-living conditions // Eur.J.Nutr. – 2003. – Vol.42. – P.111–117.
275. Leeds A.R. Dietary fibre: mechanisms of action // Int.J.Obes. – 1987. – Vol.11 (Suppl.1). – P.3–7.
276. Leeman M., Ostman E., Bjorck I. Glycaemic and satiating prop-erties of potato products // Eur J Clin Nutr 2008 62, 87–95.
277. Ley S.H., Hamdy O., Mohan V., Hu F.B. Prevention and man-agement of type 2 diabetes: dietary components and nutritional strategies // Lancet. – 2014. – Vol.383, № 9933. – P.1999–2007.
278. Li D. The association between vitamin D deficiency and diabetic nephropathy in type 2 diabetic patients / D. Li, Y. Zhang, B. Ding et al. // Zhonghua Nei Ke Za Zhi. – 2013. – Vol.52, N.11. – R. 4–970.
279. Li R., Zhang P., Barker L.E., et al. Cost-effectiveness of inter-ventions to prevent and control diabetes mellitus: a systematic review // Diabetes Care. – 2010. – Vol.33. – P.1872–1894.
280. Lichtenstein A.H., Schwab U.S. Relationship of dietary fat to glucose metabolism // Atherosclerosis. – 2000. – Vol.150. – P.227– 243.
281. Liese A.D., Schulz M., Fang F. et al. Dietary glycemic index and glycemic load, carbohydrate and fiber intake, and measures of insulin sensitivity, secretion, and adiposity in the Insulin Resistance Atheroscle-rosis Study // Diabetes Care. – 2005. – Vol.28. – P.2832–2838.
282. Linn T, Geyer R, Prassek S, Laube H. Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus // J.Clin.Endocrinol.Metab. – 1996. – Vol.81. – P.3938–3943.
283. Linn T., Santosa B., Grönemeyer D. et al. Effect of long-term dietary protein intake on glucose metabolism in humans // Diabetologia. – 2000. – Vol.43, N.10. – P.1257–1265.
284. Litherland G.J., Hajduch E., Gould G.W., Hundal H.S. Fructose transport and metabolism in adipose tissue of Zucker rats: diminished GLUT5 activity during obesity and insulin resistance // Mol.Cell.Biochem. – 2004. – Vol.261. – P.23–33.
285. Livesey G., Taylor R., Livesey H., Liu S. Is there a dose-response relation of dietary glycemic load to risk of type 2 diabetes? Meta-analysis of prospective cohort studies // Am.J.Clin.Nutr. – 2013. – Vol.97. – P.584–596.
286. Lucotti P., Setola E., Monti L.D. et al. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diets and exercise training program in obese, insulin-resistant type 2 diabetic patients // Am.J.Physiol.Endocrinol.Metab. – 2006. – Vol.291. – P.E906–E912.
287. Lupton J.R., Trumbo P.R. Dietary fiber // Modern nutrition in health and disease. 8th ed. / M.E.Shils; associate editors, M.Shike….. [et al.]. 10th ed. 2006. – P.83–91.
288. Ma B., Lawson A.B., Liese A.D. et al. Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association // Am.J.Epidemiol. – 2006. – Vol.164, № 5. – P.449–458.
289. Ma X.Y, Liu J.P., Song Z.Y. Glycemic load, glycemic index and risk of cardiovascular diseases: meta-analyses of prospective studies // Atherosclerosis; 2012; 223 (2): 491–6.
290. MacLean C.H., Mojica W.A., Morton S.C. et al.. Effects of omega–3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis // Evid.Rep.Technol.Assess. (Summ). – 2004. – № 89. – P.1–4.
291. Manco M., Calvani M., Mingrone G. Effects of dietary fatty ac-ids on insulin sensitivity and secretion // Diab.Obes.Metab. – 2004. – Vol.6. – P.402–413.
292. Maggio C.A., Pi-Sunyer F.X. The prevention and treatment of obesity. Application to type 2 diabetes // Diabetes Care. – 1997. – Vol.20. – P.1744–1466.
293. Maki KC, Phillips AK Dietary substitutions for refined carbo-hydrate that show promise for reducing risk of type 2 diabetes in men and women // J.Nutr. – 2015. – Vol.145, № 1. – P.159S–163S.
294. Manders R.J., Koopman R., Sluijsmans W.E, et al. Co-ingestion of a protein hydrolysate with or without additional leucine effectively re-duces postprandial blood glucose excursions in Type 2 diabetic men // J Nutr. – 2006. – Vol.136. – P.1294–1299.
295. Manders RJ, Praet SF, Meex RC, et al. Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients // Diabetes Care. – 2006. – Vol.29. – P.2721–2722.
296. Mann J. Free sugars and human health: sufficient evidence for action? // Lancet. – 2004. – Vol.363. – P.1068–1070.
297. Mann J.I. Nutrition recommendations for the treatment and pre-vention of type 2 diabetes and the metabolic syndrome: an evidenced-based review // Nutr.Rev. – 2006. – Vol.64. – P.422–427.
298. Mannino G.C., Sesti G. Individualized Therapy for Type 2 Dia-betes. Clinical Implications of Pharmacogenetic Data // Mol.Diagn.Ther. – 2012. – Vol.16. – P.285–302.
299. Mannucci E., Ognibene A., Cremasco F. et al. Plasma adiponectin and hyperglycaemia in diabetic patients // Clin.Chem.Lab.Med. – 2003. – Vol. 41. – P.1131–1135.
300. Marcovic T.P., Jenkins A.B., Campbeli L.V. et al. The determi-nants of glycemic responses to diet restriction and weight loss in obesity and NIDDM // Diabetes Care. – 1998. – Vol.21. – P.687–694.
301. Martino L1, Novelli M, Masini M. et al. Dehydroascorbate pro-tection against dioxin-induced toxicity in the beta-cell line INS-1E // Toxicol Lett. – 2009. – Vol.189, № 1. – P.27–34.
302. Matthews D.E. Proteins and amino acids // Modern nutrition in health and disease. 8th ed. / M.E.Shils; associate editors, M.Shike….. [et al.]. 10th ed. 2006. – P.23–61.
303. McAuley K, Mann J. Thematic review series: Patient-Oriented Research. Nutritional determinants of insulin resistance // J.Lipid Res. – 2006. – Vol.47. – P.1668–1676.
304. McKeown N.M., Meigs J.B., Liu S. et al. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort // Diabetes Care. – 2004. – Vol.27. – P.538–546.
305. Meyer K.A., Kushi L.H., Jacobs D.R. Jr. et al. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women // Am.J.Clin.Nutr. – 2000. – Vol.71. – R.921–930.
306. Meyer K.A., Kushi L.H., Jacobs D.R.Jr., Folsom A.R. Dietary fat and incidence of type 2 diabetes in older Iowa women // Diabetes Care. – 2001. – Vol.24. – R.1528–1535.
307. Modern nutrition in health and disease. Senior editor, M.E.Shils; associate editors, M.Shike….. [et al.]. 10th ed. 2006; 2068 p.
308. Mooradian A.D. Micronutrients in diabetes mellitus // Drugs, Diet and Disease. – 1999. – Vol.2. – P.183–200.
309. Mooradian A.D., Failla M., Hoogwerf B. et al. Selected vitamins and minerals in diabetes // Diabetes Care. – 1994. – Vol.17, № 5. – R.464–479.
310. Mooradian A.D., Morley J.E. Micronutrient status in diabetes mellitus // Am.J.Clin.Nutr. – 1987. – Vol.45, № 5. – R.877–895.
311. Moore W.T., Bowser S.M., Fausnacht D.W. et al. Beta Cell Function and the Nutritional State: Dietary Factors that Influence Insulin Secretion // Curr.Diab.Rep. – 2015. – Vol.15, № 10. – R.76.
312. Morris N.J., Wang S.L., Stevens L.K. et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabe-tes // Diabetol. 2001. Vol. 44 (Suppl. 2). S. 1 4–21.
313. Mostad L.L., Bjerve K.S., Bjorgaas M.R., Grill V. Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation // Am.J.Clin.Nutr. – 2006. – Vol.84. – P.540–550.
314. Mozaffarian D. Trans fatty acids – effects on systemic inflam-mation and endothelial function // Atheroscler Suppl – 2006. – Vol.7. – P.29–32.
315. Nagao T., Komine Y., Soga S. et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men // Am.J.Clin.Nutr. – 2005. – Vol.81.– P.122–129.
316. Nagi D.K., Hendra T.J., Ryle A.J. et al. The relationship of con-centrations of insulin, intact proinsulin and 32 33 split proinsulin with cardiovascular risk factor in type 2 (non-dependent) diabetes subjects // Diabetologia. – 1990. – Vol.33, № 9. – R.532–537.
317. Narita T, Koshimura J, Meguro H, Kitazato H, Fujita H, Ito S: Determination of optimal protein contents for a protein restriction diet in type 2 diabetic patients with microalbuminuria // Tohoku J.Exp.Med. – 2001. – Vol.193. – P.45–55.
318. National Task Force on the Prevention and Treatment of Obesi-ty: Very low-calorie diets // JAMA. – 1993. – Vol.270. – P.967 974.
319. Nauck M.A. Incretin therapies for type 2 diabetes mellitus: properties, function, and clinical implications // Am.J.Med. – 2011. – Vol.124 (1 Suppl.). – P.S3–S18.
320. Navaya Y., Minami A., Harada N. et al. Taurine improves insulin sensitivity in the Otsuka Long-Evans Takushima fatty rat, a model of spontaneous type 2 diabetes // Am.J.Clin.Nutr. – 2000. – Vol.71. – P.54–58.
321. Nettleton JA, Katz R. N-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review // J.Am.Diet.Assoc. – 2005. – Vol.105, N 3. – P.428–440.
322. Newsholme P., Brennan L., Bender K. Amino Acid Metabolism, β-Cell Function, and Diabetes // Diabetes. – 2006. – Vol.55 (Suppl. 2). – P.S39–S47.
323. Newsholme P, Brennan L, Rubi B, Maechler P. New insights into amino acid metabolism, beta-cell function and diabetes // Clin Sci (Lond). – 2005. – Vol.108. – P.185–194.
324. Nilsson M., Stenberg M., Frid A.H et al. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins // Am J Clin Nutr. – 2004. – Vol.80. – P.1246–1253.
325. Nordt T.K., Besenthal I., Eggstein M., Jakober B. Influence of breakfasts with different nutrient contents on glucose, C peptide, insulin, glucagon, triglycerides, and GIP in non-insulin-dependent diabetics // Am.J.Clin.Nutr. – 1991. – Vol.53, № 1. – P.155–160.
326. Nutrition and type 2 diabetes: etiology and prevention / Ed. M.A.Pereira. – CRC Press. – 2014.
327. Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association // Diabetes Care. – 2007. – Vol.30 (suppl.1). – P.S48–S65.
328. Nuttall F.Q., Gannon M.C. Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects // Diabetes Care. – 1991. – Vol.14, № 9. – P.824–838.
329. O’Dea K., Snow P., Nestel P. Rate of starch hydrolysis in vitro as a predictor of metabolic responses to complex carbohydrate in vivo // Am.J.Clin.Nutr. – 1981. – Vol.34, № 10. – P.1991–1993.
330. O'Donnell LJ1, Emmett PM, Heaton KW. Failure of salt to in-crease starch digestibility and glycaemic response // Br Med J (Clin Res Ed). – 1998. – Vol.296 (6619). – P.394.
331. Ohkubo Y., Kishikawa H., Araki E. et al. Intensive insulin ther-apy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a ran-domized prospective 6-year study // Diabetes Res.Clin.Pract. – 1995. – Vol.28. – P.103–117.
332. Page G. Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease / G. Page, D. Laight, M. Cummings // J. Clin. Pract. – 2011. – Vol.65, № 6. – R.684–690.
333. Paolisso G., Sgambato S., Gambardella A. et al. Dayly magne-sium supplements improve glucose handling in elderly subjects // Am.J.Clin.Nutr. – 1992. – Vol.55. – P.1161 1167.
334. Parillo M., Rivellese A.A., Ciardullo A.V. et al. A high mono-unsaturated fat/low carbohydrate diet improves peripheral insulin sensi-tivity in non-insulin dependent diabetic mellitus // Metabolism. – 1992. – Vol.41. – P.1373–1377.
335. Pérez-Jiménez F., López-Miranda J., Pinillos M.D. et al. A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons // Diabetolodia. – 2001. – Vol.44. – P.2038–2043.
336. Pfutzner A., Haima P. Metabolic Syndrome and associated pa-thologies. TECOmedical Clinical and Technical Review, 2013.
337. Philippou E., Bovill-Taylor C., Rajkumar C. et al. Preliminary report: the effect of a 6-month dietary glycemic index manipulation in addition to healthy eating advice and weight loss on arterial compliance and 24-hour ambulatory blood pressure in men: a pilot study // Metabo-lism. – 2009. – Vol.58, № 12. – P.1703–1708.
338. Piatti P.M., Monti L.D., Valsecchi G. et al. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients // Diabetes Care. – 2001. – Vol.24. – P.875–880.
339. Piero M.N., Nzaro G.M., Njagi J.M. Diabetes mellitus – a dev-astating metabolic disorder // Asian Journal of Biomedical and Pharma-ceutical Sciences. – 2014. – Vol.4 (40). – P.1–7.
340. Pijls L.T., de Vries H., van Eijk J.T., Donker A.J. Protein re-striction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial // Eur.J.Clin.Nutr. – 2002 – Vol.56. – P.1200–1207.
341. Pi-Sunyer F.X. Weight loss and mortality in type 2 diabetes // Diabetes Care. – 2000. – Vol.23, №10. – R.1451–1452.
342. Qi Lu, Rimm E., Liu S. et al. Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men // Diabetes Care. – 2005. – Vol.28. – P.1022–1028.
343. Quilez J., Garcia-Lorda P., Salas-Salvado J. Potential uses and benefits of pliytosterols in diet: present situation and future directions // Clin. Nutr. 2003. -Vol. 22.-P. 343–351.
344. Rabinovitz H., Friedensohn A., Leibovitz A. et al. Effect of chromium supplementation on blood glucose and lipid levels in type 2 di-abetes mellitus elderly patients // Int.J.Vitam.Nutr.Res. – 2004 – Vol.74. – P.178–82.
345. Rasmussen B.M., Vessby B., Uusitupa M. Effects of dietary saturated, monounsaturated, and n–3 fatty acids on blood pressure in healthy subjects // Am.J.Clin.Nutr. – 2006. – Vol. 83, No. 2. – R.221–226.
346. Rea R., Thompson L.U., Jenkins D.J.A. Lectins in foods and their relation to starch digestibility // Nutr.Res. – 1985. – Vol.5, № 9 – P.919–929.
347. Reaven G.M. The insulin resistance syndrome: definition and dietary approaches to treatment // Annu.Rev.Nutr. – 2005. – Vol.25. – P.391–406.
348. Regulation (EC) N1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods // Official Journal of the European Union. 2006. L. 404. P.9–25.
349. Remer T, Pietrzik K, Manz F. A moderate increase in daily pro-tein intake causing an enhanced endogenous insulin secretion does not al-ter circulating levels or urinary excretion of dehydroepiandrosterone sul-fate // Metabolism. – 1996. – Vol.45, № 12. – P.1483–1486.
350. Riccardi G., Giacco R., Rivellese A.A. Dietary fat, insulin sensi-tivity and the metabolic syndrome // Clin.Nutr. – 2004. – Vol.23. – P.447–456.
351. Risérus U., Arner P., Brismar K., Vessby B. Treatment with die-tary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome // Diabetes Care. – 2002. – Vol.25. – P.1516–1521.
352. Riserus U., Willett W.C., Hu F.B. Dietary fats and prevention of type 2 diabetes // Progress in Lipid Research. – 2009. – Vol.48. – P.44–51.
353. Rivellese A.A., De Natale C., Lilli S. Type of dietary fat and in-sulin resistance // Ann.N.Y.Acad.Sci. – 2002. – Vol.967. – P.329–335.
354. Robertson M.D., Bickerton A.S., Dennis A.L. et al. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism // Am.J.Clin.Nutr. – 2005. – Vol.82. – P.559–567.
355. Rodriguez-Moran M., Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial // Di-abetes Care. – 2003. – Vol.26. – P.1147–1152.
356. Romero-Corral A. Caples S.M., Lopez-Jimenez F., Somers V.K. Interactions between obesity and obstructive sleep apnea: implications for treatment // Chest. – 2010. – Vol.137, №3. – R.711–719.
357. Ros E. Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes // Am.J.Clin.Nutr. – 2003. – Vol.78. – P.617S–625S.
358. Ross S.W., Brand J.C., Thorburn A.W., Truswell A.S. Glycemic index of processed wheat products // Am.J.Clin.Nutr. – 1987. – Vol.46, № 4. – P.631–635.
359. Ryan-Harshman M., Aldoori W. New dietary reference intakes for macronutrients and fibre // Can.Fam.Physician. – 2006. – Vol.10. – P.177–179.
360. Sajilata M.G., Singhal R.S., Kulkarni P.R. Resistant Starch – A Review // Comprehensive Reviews in Food Science and Food Safety. – 2006. – Vol.5, № 1. – P.1–17.
361. Salehi A, Gunnerud U, Muhammed SJ, Ostman E, Holst JJ, Björck I, Rorsman P. The insulinogenic effect of whey protein is partially mediated by a direct effect of amino acids and GIP on β-cells // Nutr.Metab. – 2012. – Vol.9, № 1. – P.48.
362. Salmeron J., Hu F.B., Manson J.E. et al. Dietary fat intake and risk of type 2 diabetes in women // Am J Clin Nutr 2001;73:1019–1026.
363. Salmeron J., Manson J.E., Stampfer M.J. et al. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women // JAMA. – 1997. – Vol.277, № 6. – P.472–477.
364. Sargrad K.R., Homko C., Mozzoli M., Boden G. Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus // J.Am.Diet.Assoc. – 2005. – Vol.105. – P.573–580.
365. Saw S.M. Genetic, dietary and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore / S.M. Saw, J.M. Yuan, C.N. Ong et al. // Am. J. Clin.Nutr. – 2001. – Vol.73. – R.232–239.
366. Sheard N.F., Clark N.G., Brand-Miller J.C. et al. Dietary Car-bohydrate (Amount and Type) in the Prevention and Management of Dia-betes // Diabetes Care. – 2004. – Vol.27. – P.2266–2271.
367. Shiraiwa T., Kaneto H., Miyatsuka T. et al. Postprandial hyper-glycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients // Biochem.Biophys.Res.Commun. – 2005. – Vol.336. – P.339–345.
368. Sidelka G., Skrha J., Hilgertova J., Justova V. Vliv kratkodobe redukcni diety na pusobeni inzulini u diabetes mellitus 2 typu // Cas.Lek.Cesk. – 1997. – Vol.136. – R.530–532.
369. Skrha J., Sidelka G., Kvasnicka J., Hilgertova J. Insulin action and fibrinolysis by vitamin E in obese type 2 diabetes mellitus // Diabetes Res.Clin.Pract. – 1999. – Vol.44. – R.27–33.
370. Song Y., Manson J.E., Buring J.E., Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women // Diabetes Care. – 2004. – Vol.27. – R.59–65.
371. Song Y.J., Sawamura M., Ikeda K., et al. Soluble dietary fibre improves insulin sensitivity by increasing muscle GLUT-4 content in stroke-prone spontaneously hypertensive rats // Clin.Exp.Pharmacol. Physiol. – 2000. – Vol.27. – R.41–45.
372. Spiller G.A., Jensen C.D., Pattison T.S. et al. Effect of protein dose on serum glucose and insulin response to sugars // Am.J.Clin.Nutr. – 1987. – Vol.46, № 3. – P.474–480.
373. Storlien L.H., Baur L.A., Kriketos A.D. et al. Dietary fats and insulin action // Diabetolodia. – 1996. – Vol.39. – P.621–631.
374. Stott D., MacIntosh G., Lowe G. et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease // Am.J.Clin.Nutr. – 2005. – Vol.82. – P.1320–1326.
375. Sun L., Ranawana D.V., Leow M.K., Henry C.J. Effect of chicken, fat and vegetable on glycaemia and insulinaemia to a white rice-based meal in healthy adults // Eur J Nutr. – 2014. – Vol.53, № 8. – P.1719–1726.
376. The European health report 2015. Targets and beyond – reaching new frontiers in evidence. The European health report 2015 (ISBN 978 92 890 1430 4).
377. Thirunavukkarasu V., Anitha Nandhini A.T., Anuradha C.V. Ef-fect of alpha-lipoic acid on lipid profile in rats fed a high-fructose diet // Exp.Diabesity Res. – 2004. – Vol.5. – P.195–200.
378. Thomas D., Elliott E.J. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus // Cochrane Database Syst Rev. 2009 Jan 21;(1): CD006296. doi: 10.1002/14651858.CD006296.pub2.
379. Thompson L.U., Button C.L., Jenkins D.J.A. Phytic acid and calcium affect the in vitro rate of navy bean starch digestion and blood glucose response in humans // Am.J.Clin.Nutr. – 1987. – Vol.46, № 3. – P.467–473.
380. Thorburn A.W., Brand J.C., Truswell A.S. Salt and the glycaemic response // Br.Med.J. [Clin.Res]. – 1986. – Vol.292 (6537). – P.1697–1699.
381. Thorburn A., Muir J., Proietto J. Carbohydrate fermentation de-creases hepatic glucose output in healthy subjects // Metabolism. – 1993. – Vol.42, № 6. – P.780–785.
382. Thorne M.J., Thompson L.U., Jenkins D.J.A. Factors affecting starch digestibility and the glycemic response with special reference to legumes // Am.J.Clin.Nutr. – 1983. – Vol.38, № 3. – P.481–488.
383. Tiwari S., Pratyush D., Gupta B. et al. Prevalence and severity of vitamin D deficiency in patients with diabetic foot infection // Br. J. Nutr. – 2013. – Vol.109, N.1. – R. 99–102.
384. Tormo M.A., Gil-Exojo I., Romero de Tejada A., Campillo J.E. White bean amylase inhibitor administered orally reduces glycaemia in type 2 diabetic rats // Br.J.Nutr. – 2006. – Vol.96. – P.539–544.
385. Ueno M., Bezerra R.M., Silva M.S. et al. A high-fructose diet induces changes in pp185 phosphorylation in muscle and liver of rats // Braz.J.Med.Biol.Res. – 2000. – Vol.33. – P.1421–1427.
386. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood- glucose control with sulphonylureas or insulin compared with tra-ditional treatment and risk of complications in patients with type 2 diabe-tes // Lancet. – 1998. – Vol.352. – P.837–853.
387. Van Loon L.J., Kruijshoop M., Menheere P.P. et al. Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes // Diabetes Care. – 2003. – Vol.26. – P.625–630.
388. Van Loon L.J.C., Saris W.H.M., Verhagen H., Wagenmakers A.J.M. Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate // Am.J.Clin.Nutr. – 2000. – Vol.72. – P.96–105.
389. Vessby B., Uusitupa M., Hermansen K. et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study // Diabetolodia. – 2001. – Vol.44. – P.312–319.
390. Vladeva S.V., Terzieva D.D., Arabadjiiska D.T. Effect of chro-mium on the insulin resistance in patients with type II diabetes mellitus // Folia Med. (Plovdiv). – 2005. – Vol.47. – P.59–62.
391. Wang C., Harris W.S., Chung M. et al. n-3 fatty acids from fish or fish-oil supplements, but not {alpha}-linolenic acid, benefit cardiovas-cular outcomes in primary- and secondary-prevention studies: a systematic review // Am.J.Clin.Nutr. – 2006. – Vol.84. – P.5–17.
392. Wareham N.J., Byrne C.D., Williams R. et al. Fasting proinsulin concentrations predict the development of type 2 diabetes // Diabetes Care. – 1999. – Vol.22. – P.262–270.
393. Weickert M.O., Mohlig M., Schöfl C. et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women // Diabetes Care. – 2006. – Vol.29. – P.775–780.
394. Weickert M.O., Pfeiffer A F.H. Metabolic Effects of Dietary Fi-ber Consumption and Prevention of Diabetes // J. Nutr. – 2008. – Vol.138. – P.439–442.
395. Welch I.McL., Bruce C., Hill S.E., Read N.W. Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: possible implications for the dietary management of diabetes mellitus // Clin.Sci. – 1987. – Vol.72, № 2. - P.209–216.
396. Weyer C., Funahashi T., Tanaka S. et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia // J.Clin.Endocrinol.Metab. – 2001 – Vol.86. – P.1930–1935.
397. Wilcox G. Insulin and Insulin Resistance // Clin.Biochem.Rev. – 2005. – Vol.26. – P.19–39.
398. Williams K.V., Kelley D.E. Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes // Diabe-tes Obes.Metab. – 2000. – Vol.2. – P.121 129.
399. Wood P.J., Beer M.U., Butler G. Evaluation of role of concen-tration and molecular weight of oat ß-glucan in determining effect of vis-cosity on plasma glucose and insulin following an oral glucose lead. // Br.J.Nutr. – 2000. – Vol.84. – P.19–23.
400. Woodward J. R., Phillips D. R., Fincher G. B. Water-soluble (1→3), (1→4)-β-d-glucans from barley (Hordeum vulgare) endosperm // I. Physicochemical properties. Carbohydrate Polymers. – 1983. – Vol.3. – P.143–156.
401. Wolever T.M. Dietary carbohydrates and insulin action in hu-mans // Br.J.Nutr. – 2000. – Vol.83 (Suppl.1). – P.S97– S102.
402. Wolever T.M.S. Relationship between dietary fiber content and composition in foods and the glycemic index // Am.J.Clin.Nutr. – 1990. – Vol.51, № 1. – P.72–75.
403. Wolever T.M.S., Bolognesi C. Prediction of glucose and insulin responses of normal subjects after consuming mixed meals varing the en-ergy, protein, fat, carbohydrate and glycemic index // J.Nutr. – 1996. – Vol.126, № 11. – P.2807–2812.
404. Wolever T.M.S., Jenkins D.J.A., Jenkins A.L., Josse R.G. The glycemic index: methodology and clinical implications // Am.J.Clin.Nutr. – 1991. – Vol.54, № 5. – P.846–854.
405. Wolever T.M.S., Katzman-Relle L., Jenkins A.L., et al. Glycemic index of 102 complex carbohydrate foods in patients with diabetes // Nutr.Res. – 1994. – Vol.14, № 5. – P.651–669.
406. Wylie-Rosett J. Evaluation of protein in dietary management of diabetes mellitus // Diabetes Care. – 1988. – Vol.11, № 2. – P.143–148.
407. Yahia R.B., Lichnovska R., Brychta T. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferators-activated receptors (PPARs) in saccharide and lipid metabo-lism // Biomed.Pap.Med.Fac.Univ.Palacky Olomouc Czech Repub. – 2005. – Vol.149. – P.237–241.
408. Yeh G.Y., Eisenberg D.M., Kaptchuk T.J., Phillips R.S. Sys-tematic review of herbs and dietary supplements for glycemic control in diabetes // Diabetes Care. – 2003. – Vol.26. – P.1277–1294.
409. Yilmaz H., Kaya M., Sahin M. et al. Is vitamin D status a predictor glycaemic regulation and cardiac complication in type 2 diabetes mellitus patients // Diabetes Metab. Syndr. – 2012. – Vol.6, N.1. – R.28–31.
410. Yoon J.H., Thompson L.U., Jenkins D.J.A. The effect of phytic acid on in vitro rate of starch digestibility and blood glucose response // Am.J.Clin.Nutr. – 1983. – Vol.38, № 6. – P.835–842.
411. Yoshioka N., Kuzuya T., Matsuda A., Iwamoto Y. Effects of di-etary treatment on serum insulin and proinsulin response in newly diag-nosed NIDDM // Diabetes. – 1989. – Vol.38, № 2. – P.262–266.
412. Young V., Ajami A. Glutamine: the emperor or his clothes? // J Nutr. – 2001. – Vol.131 (9 Suppl). – P.2449S–2459S.
413. Zethelius B et al. Insulin resistance, impaired early insulin re-sponse and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men // Diabetes Care. – 2004. – Vol.27. – P.1433–1438.
414. Zhou S.S., Li D., Sun W.P. et al. Nicotinamide overload may play a role in the development of type 2 diabetes // World J.Gastroenterol. – 2009. – Vol.15, № 45. – P.5674–5684.